Claire Fraser, Ph.D.
Board Member
Seres Therapeutics, Inc. (MCRB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Claire Fraser, Ph.D.
Claire Fraser, Ph.D. is recorded as Board Member at Seres Therapeutics, Inc. (MCRB). Seres Therapeutics, Inc. reported in an 8-K filed January 5, 2023 that Claire Fraser, Ph.D. was appointed Class II director, effective January 4, 2023.
“On January 4, 2023, the Board of Directors (the "Board") of Seres Therapeutics, Inc. (the "Company") increased its size to provide for a total of ten directors authorized to serve on the Board and appointed Claire Fraser, Ph.D. as a Class II director of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Seres Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Marella Thorell CEO, CFO, Chief Accounting Officer
- Richard N. Kender CEO, Chairman, Board Member
- Roger J. Pomerantz CEO
- Kelly Brady COO
- Kelly Brady, M.S. COO
- David S. Ege CTO
- David Arkowitz Chief Accounting Officer
- Eric Shaff Chief Accounting Officer
- Claire M. Fraser, Ph.D. Board Member
- Dennis A. Ausiello Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.